FOXO Key Statistics, Chart & Performance
The current stock price of FOXO is 0.0922 USD. In the past month the price decreased by -67.37%. In the past year, price decreased by -96.68%.
FOXO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PLTR | PALANTIR TECHNOLOGIES INC-A | 276.34 | 421.36B | ||
| CRM | SALESFORCE INC | 22.62 | 248.02B | ||
| APP | APPLOVIN CORP-CLASS A | 70.14 | 208.36B | ||
| INTU | INTUIT INC | 30.99 | 181.64B | ||
| ADBE | ADOBE INC | 16.18 | 141.92B | ||
| SNPS | SYNOPSYS INC | 39.61 | 98.05B | ||
| CDNS | CADENCE DESIGN SYS INC | 45.35 | 86.78B | ||
| ADSK | AUTODESK INC | 28.02 | 58.63B | ||
| WDAY | WORKDAY INC-CLASS A | 24.17 | 55.17B | ||
| DDOG | DATADOG INC - CLASS A | 66.67 | 45.83B | ||
| MSTR | STRATEGY INC | 3.77 | 49.27B | ||
| ROP | ROPER TECHNOLOGIES INC | 22.17 | 46.77B |
Related stock screener links
About FOXO
Company Profile
FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota. The company went IPO on 2020-12-11. The firm owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. The company offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Company Info
FOXO TECHNOLOGIES INC-CL A
729 Washington Ave. N, Suite 600
Minneapolis MINNESOTA US
Employees: 135
Phone: 16125629447
FOXO TECHNOLOGIES INC-CL A / FOXO FAQ
What does FOXO TECHNOLOGIES INC-CL A do?
FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota. The company went IPO on 2020-12-11. The firm owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. The company offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
What is the stock price of FOXO TECHNOLOGIES INC-CL A today?
The current stock price of FOXO is 0.0922 USD. The price decreased by -9.96% in the last trading session.
Does FOXO TECHNOLOGIES INC-CL A pay dividends?
FOXO does not pay a dividend.
What is the ChartMill technical and fundamental rating of FOXO stock?
FOXO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the valuation of FOXO TECHNOLOGIES INC-CL A (FOXO) based on its PE ratio?
FOXO TECHNOLOGIES INC-CL A (FOXO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-20.41).
How many employees does FOXO TECHNOLOGIES INC-CL A have?
FOXO TECHNOLOGIES INC-CL A (FOXO) currently has 135 employees.
What is the market capitalization of FOXO stock?
FOXO TECHNOLOGIES INC-CL A (FOXO) has a market capitalization of 492.35K USD. This makes FOXO a Nano Cap stock.
FOXO Technical Analysis
FOXO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to FOXO. FOXO has a bad profitability rating. Also its financial health evaluation is rather negative.
FOXO Financial Highlights
Over the last trailing twelve months FOXO reported a non-GAAP Earnings per Share(EPS) of -20.41. The EPS increased by 84.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.86% | ||
| ROE | -128.8% | ||
| Debt/Equity | 0.62 |